These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33642467)

  • 1. Efficacy of Oral Vitamin D
    Sattar F; Almas U; Ibrahim NA; Akhtar A; Shazad MK; Akram S; Khan MSN; Murtaza G
    J Nutr Sci Vitaminol (Tokyo); 2021; 67(1):68-71. PubMed ID: 33642467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India.
    Poonia K; Thami GP; Bhalla M; Jaiswal S; Sandhu J
    J Cosmet Dermatol; 2019 Feb; 18(1):401-407. PubMed ID: 29774652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of QR678 Neo
    Shome D; Kapoor R; Surana M; Vadera S; Shah R
    J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium?
    Koç Yıldırım S; Erbağcı E; Demirel Öğüt N
    J Cosmet Dermatol; 2022 May; 21(5):1809-1815. PubMed ID: 35201647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral supplementation in female telogen effluvium: a clinical and instrumental objective evidence of efficacy and tolerability of new oral cosmetic treatment.
    Starace M; Carpanese MA; Alessandrini A; Bruni F; Piraccini BM
    Ital J Dermatol Venerol; 2023 Feb; 158(1):55-59. PubMed ID: 36645365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study.
    Milani M; Colombo F;
    Skin Res Technol; 2023 Jun; 29(6):e13381. PubMed ID: 37357646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium.
    Yorulmaz A; Hayran Y; Ozdemir AK; Sen O; Genc I; Gur Aksoy G; Yalcin B
    J Cosmet Dermatol; 2022 Jun; 21(6):2610-2617. PubMed ID: 34449961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telogen Effluvium - a review of the science and current obstacles.
    Chien Yin GO; Siong-See JL; Wang ECE
    J Dermatol Sci; 2021 Mar; 101(3):156-163. PubMed ID: 33541773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telogen effluvium and COVID-19: a cross-sectional study.
    Aldahish A; Vasudevan R; Salem H; Alqahtani A; AlQasim S; Alqhatani A; Al Shahrani M; Al Mohsen L; Hajla M; Calina D; Sharifi-Rad J
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7823-7830. PubMed ID: 37667959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial.
    El-Dawla RE; Abdelhaleem M; Abdelhamed A
    Indian J Dermatol Venereol Leprol; 2023; 89(2):195-203. PubMed ID: 35593290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the relationship of digital phototrichogram findings of patients with diffuse hair loss with blood TSH, ferritin and vitamin B12 levels.
    Bilik L; Kokcam I; Esen M
    North Clin Istanb; 2024; 11(1):38-44. PubMed ID: 38357319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita.
    Quercetani R; Rebora AE; Fedi MC; Carelli G; Mei S; Chelli A; Poli E
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):808-10. PubMed ID: 20946585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of zinc in chronic telogen effluvium in serum and hair of patients with alopecia.
    Zufishan S; Haque Z; Nazar S; Afaq E; Aamir E; Rafique S
    J Pak Med Assoc; 2024 Feb; 74(1 (Supple-2)):S47-S50. PubMed ID: 38385471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity.
    Seyfi S; Alijanpour R; Aryanian Z; Ezoji K; Mahmoudi M
    J Med Life; 2022 May; 15(5):631-634. PubMed ID: 35815081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
    Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
    Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expert consensus on the management of Telogen Effluvium in India.
    Mysore V; Parthasaradhi A; Kharkar RD; Ghoshal AK; Ganjoo A; Ravichandran G; Saraswat A; Shah Y; Singh M; Remadevi TJ; Matte P
    Int J Trichology; 2019; 11(3):107-112. PubMed ID: 31360038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical study on the efficacy and tolerability of an oral supplement based on arginine, l-cystine, zinc and B6 vitamin (Cystiphane®) in patients with telogen effluvium.
    Starace M; Cedirian S; Bruni F; Alessandrini AM; Quadrelli F; Sechi A; Piraccini BM
    Ital J Dermatol Venerol; 2023 Jun; 158(3):255-261. PubMed ID: 37278502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety.
    Russo PM; Fino E; Mancini C; Mazzetti M; Starace M; Piraccini BM
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):608-611. PubMed ID: 30394586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute telogen effluvium triad after resolution.
    Contin LA; Rocha VB
    An Bras Dermatol; 2021; 96(5):605-608. PubMed ID: 34272075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.